Treatment Guidelines

Evidence-based guidelines or cosmetic treatments

Treatment Expectations

Treatment Guidelines

Thoughtfully designed protocols to enhance safety, natural outcomes, and long-term patient satisfaction.

  • FDA-approved botulinum toxin type A for aesthetic and therapeutic use.
  • Results begin within 3–7 days, full effect at 10–14 days.
  • Average duration: 3–4 months depending on metabolism and dosing.
  • Dosing individualized based on muscle strength, anatomy, and aesthetic goals.
  • Follow-up assessment recommended at 14 days for optimization.
  • Conservative dosing approach to preserve natural facial movement.
  • Hyaluronic acid and biostimulatory fillers used to restore structure and volume.
  • Product selection based on rheology, treatment depth, and anatomical region.
  • Swelling and bruising are expected and temporary.
  • Gradual, staged treatments recommended for facial harmony.
  • Emphasis on facial balance and structural support rather than overfilling.
  • Micro-aliquot technique for precision and symmetry.
  • Conservative first session to assess tissue response.
  • Focus on hydration, border definition, and proportion.
  • Swelling peaks 48–72 hours post-treatment.
  • Follow-up recommended at 2 weeks if refinement needed.
  • Controlled collagen induction therapy stimulating dermal remodeling.
  • Improves texture, fine lines, acne scarring, and tone.
  • Series of 3–4 treatments recommended for optimal results.
  • Adjuncts such as PRP or PDRN may enhance regenerative response.
  • Strict sterile protocol followed.
  • Autologous platelet-rich plasma prepared under sterile technique.
  • Used to stimulate hair follicles and improve density.
  • Initial series of 3–4 sessions spaced 4–6 weeks apart.
  • Maintenance treatments every 6–12 months.
  • Medical-grade exfoliation tailored to skin type and concern.
  • Improves pigmentation, acne, and texture irregularities.
  • Pre-treatment skincare optimization required.
  • Strict post-care adherence to prevent complications.
  • Evidence-based metabolic support using GLP-1 receptor agonists.
  • Indicated for BMI ≥30 or ≥27 with comorbidities.
  • Monthly monitoring and dose titration protocol.
  • Nutritional, muscle-preservation, and lifestyle support included.
  • Maintenance strategy developed individually to prevent rebound weight gain.

© Copyright 2026. Savannah Beauty Aesthetics. All Rights Reserved.